Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Vaxcyte, Inc. (PCVX) News - StockMarketCap

Stocks›Vaxcyte, Inc.☆

● At closeAs of Jul 2, 2026

Vaxcyte, Inc.

PCVX✓

HealthcareBiotechnologyNASDAQ

$58.39+4.12%

$8.43BMarket cap

-8.53xP/E ratio

1.38MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$58.39

$2.31 (+4.12%) · 24h

Key metrics

Market cap$8.43B+18.85%

Enterprise value$8.34B

Volume (24h)1.38M

P/E ratio (TTM)-8.53x

P/S ratio (TTM)0.00x

Dividend yield0.00%

Shares outstanding144.40M

Trading range

Previous close$56.08

Day range$55.62 - $58.49

52-week range$29.08 - $65.00

Vaxcyte, Inc. (PCVX) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news